BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10722668)

  • 1. Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin.
    Kawahara K; Morishita T; Nakamura T; Hamada F; Toyoshima K; Akiyama T
    J Biol Chem; 2000 Mar; 275(12):8369-74. PubMed ID: 10722668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
    Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
    J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
    Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
    Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
    Kishida S; Yamamoto H; Ikeda S; Kishida M; Sakamoto I; Koyama S; Kikuchi A
    J Biol Chem; 1998 May; 273(18):10823-6. PubMed ID: 9556553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    Schneikert J; Ruppert JG; Behrens J; Wenzel EM
    PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the Axin-adenomatous polyposis coli interaction.
    Spink KE; Polakis P; Weis WI
    EMBO J; 2000 May; 19(10):2270-9. PubMed ID: 10811618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin.
    Choi J; Park SY; Costantini F; Jho EH; Joo CK
    J Biol Chem; 2004 Nov; 279(47):49188-98. PubMed ID: 15355978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apical membrane localization of the adenomatous polyposis coli tumor suppressor protein and subcellular distribution of the beta-catenin destruction complex in polarized epithelial cells.
    Reinacher-Schick A; Gumbiner BM
    J Cell Biol; 2001 Feb; 152(3):491-502. PubMed ID: 11157977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
    Behrens J; Jerchow BA; Würtele M; Grimm J; Asbrand C; Wirtz R; Kühl M; Wedlich D; Birchmeier W
    Science; 1998 Apr; 280(5363):596-9. PubMed ID: 9554852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
    Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
    Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.
    Kitagawa M; Hatakeyama S; Shirane M; Matsumoto M; Ishida N; Hattori K; Nakamichi I; Kikuchi A; Nakayama K; Nakayama K
    EMBO J; 1999 May; 18(9):2401-10. PubMed ID: 10228155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
    Xing Y; Clements WK; Kimelman D; Xu W
    Genes Dev; 2003 Nov; 17(22):2753-64. PubMed ID: 14600025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of E-APC, a novel Drosophila homologue of the tumour suppressor APC.
    Hamada F; Murata Y; Nishida A; Fujita F; Tomoyasu Y; Nakamura M; Toyoshima K; Tabata T; Ueno N; Akiyama T
    Genes Cells; 1999 Aug; 4(8):465-74. PubMed ID: 10526234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon.
    Rubinfeld B; Tice DA; Polakis P
    J Biol Chem; 2001 Oct; 276(42):39037-45. PubMed ID: 11487578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
    Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
    J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene.
    Senda T; Shimomura A; Iizuka-Kogo A
    Anat Sci Int; 2005 Sep; 80(3):121-31. PubMed ID: 16158975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.